Financhill
Buy
58

IPSC Quote, Financials, Valuation and Earnings

Last price:
$0.99
Seasonality move :
-30.11%
Day range:
$0.96 - $1.03
52-week range:
$0.34 - $1.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.76x
P/B ratio:
0.50x
Volume:
1.2M
Avg. volume:
1.3M
1-year change:
-3.85%
Market cap:
$87.3M
Revenue:
$6.6M
EPS (TTM):
-$0.31

Earnings Data

Next earnings date for IPSC
Mar 19
2026
Most recent earnings per share
-$0.40
Missed by $0.01
(Nov 13/2025)
Consensus Estimate
-$0.39
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IPSC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.30 --
03/19/2026 Q4 -$83.3K -- -- -$0.24 --
11/13/2025 Q3 -- -- -$0.40 -$0.39 -$0.01
08/14/2025 Q2 -- -- -$0.38 -$0.38 -$0.00
05/15/2025 Q1 $49.6M $109.2M $0.89 $0.18 $0.71
03/19/2025 Q4 $975K $4.2M -$0.42 -$0.44 $0.01
11/05/2024 Q3 $550K $791K -$0.37 -$0.45 $0.08
08/08/2024 Q2 $666.7K $771K -$0.38 -$0.50 $0.12
05/09/2024 Q1 $225K $855K -$0.45 -$0.45 --
03/14/2024 Q4 $1.9M $268K -$0.65 -$0.53 -$0.12
11/09/2023 Q3 -- -- -$0.55 -$0.49 -$0.06
08/09/2023 Q2 -- -- -$0.56 -$0.54 -$0.02
05/11/2023 Q1 -- -- -$0.53 -$0.52 -$0.01
03/16/2023 Q4 -- -- -$0.55 -$0.58 $0.03
11/10/2022 Q3 -- -- -$0.53 -$0.60 $0.07
08/11/2022 Q2 -- -- -$0.54 -$0.50 -$0.04
05/16/2022 Q1 -- -- -$0.66 -$0.54 -$0.12
03/17/2022 Q4 -- -- -$0.51 -$0.49 -$0.02
11/10/2021 Q3 -- -- -$0.48 -$0.42 -$0.06
08/12/2021 Q2 -- -- -$1.93 -$0.38 -$1.55
03/31/2021 Q1 -- -- -$0.44 -- --
12/31/2020 Q4 -- -- -$0.37 -- --

Century Therapeutics, Inc. Earnings Questions

  • How Much did Century Therapeutics, Inc. Generate in Revenue Last Quarter?

    Century Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Century Therapeutics, Inc. Beat Earnings Last Quarter?

    Century Therapeutics, Inc. announced earnings per share of -$0.40 which represents a miss of analyst forecast a -$0.39 per share.

  • Is Century Therapeutics, Inc. Profitable?

    Century Therapeutics, Inc. reported -$3.1M that represents -$0.04 per share over the last quarter.

  • What is the Analyst Consensus for Century Therapeutics, Inc. EPS Next Year?

    Century Therapeutics, Inc.'s earnings are forecast to decrease from -$1.61 per share to -$1.63 per share next year representing a decrease of -87.57%.

  • When is Century Therapeutics, Inc.'s Earnings Date?

    Century Therapeutics, Inc.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
14
SMX alert for Dec 30

SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.

Buy
71
ZCSH alert for Dec 30

Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.

Buy
69
GDXU alert for Dec 30

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock